Sanofi and Regeneron’s appeal to suspend Amgen injunction denied

12-01-2017

Sanofi and Regeneron’s appeal to suspend Amgen injunction denied

360b / Shutterstock.com

A US district court has denied Sanofi and Regeneron’s motion to suspend an injunction which was obtained by Amgen earlier this month.


Regeneron, Sanofi, Amgen, patent, injunction, Praluent, Repatha, Federal Circuit

LSIPR